Consensus $3.17B. Lowers FY23 adjusted EBITDA view to $630M-$650M from $650M-$680M. Sees FY23 capital expenditures 10%-12%.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AHCO:
- 3 Best Stocks to Buy Now, 10/23/2023, According to Top Analysts
- AdaptHealth price target lowered to $17 from $21 at Baird
- AdaptHealth price target lowered to $14 from $18 at Truist
- AdaptHealth price target lowered to $11 from $13 at BofA
- AdaptHealth terminates agreement with Teufel, to resume search for new CEO
